US equities |

SPCX $147.79 ▲+0.00% MU $896.07 ▲+0.00% TSLA $373.71 ▲+0.00% NVDA $216.47 ▲+0.00% SNDK $1,365.38 ▲+0.00% SKHY $139.79 ▲+0.00% INTC $91.69 ▲+0.00% AMD $534.74 ▲+0.00%

Market Indicators

Chart for State Street SPDR Dow Jones Industrial Average ETF Trust (NY: DIA)

Name	Price	Change	% Change
DJIA ETF	524.36	+0.00	0.00%
S&P ETF	769.05	+0.00	0.00%
QQQ	717.63	+0.00	0.00%
Gold RT	4,139.30	-3.30	-0.08%
Oil RT	99.13	+1.31	+1.34%
Bitcoin RT	83,482.98	+585.93	+0.71%

World Markets

Index		Price	Change	% Change
	FTSE	10,733.00	-31.69	-0.29%
	CAC	5,517.52	+0.00	0.00%
	NIKKEI	64,075.42	+0.00	0.00%
	HSI	23,867.74	-319.09	-1.32%
	S&P/TSX	36,107.96	+0.00	0.00%

Sector ETFs

Sector	% Change	YTD %
Basic Materials	0.00%	+16.84%
Consumer Goods	0.00%	+15.95%
Energy	0.00%	+47.17%
Financial Services	0.00%	+0.23%
Healthcare	0.00%	+15.54%
Industrial	0.00%	+4.48%
Technology	0.00%	+26.74%
Telecom	0.00%	+15.39%
Utilities	0.00%	-1.96%

Market News

News headline image

GE Vernova's $176 Billion Backlog, Explained ↗

Today 5:10 EDT

Via The Motley Fool

News headline image

2 Nasdaq-100 Stocks to Buy Before They Soar 105% and 130%, According to Wall Street ↗

Today 5:08 EDT

Via The Motley Fool

News headline image

Alnylam Is Now Solidly Profitable. Why Are Investors Treating It Like a Broken Biotech? ↗

Today 5:04 EDT

Via The Motley Fool

News headline image

Arcus Biosciences Sees $5B-$10B RCC Opportunity for Casdatifan at Investor Day ↗

Today 5:02 EDT

Bath & Body Works (NYSE:BBWI) Passes the Dividend Quality Screen for Income Investors ↗

Today 5:10 EDT

Currencies

More Currencies

▼ -0.20% today

▲ +0.09% today

▼ -0.03% today

▼ -0.04% today

More News

News headline image

Arcus Biosciences Sees $5B-$10B RCC Opportunity for Casdatifan at Investor Day ↗

Today 5:02 EDT

Arcus Biosciences (NYSE:RCUS) presented updated clinical and translational data for casdatifan, its investigational HIF-2 alpha inhibitor, outlining development plans across first-line, second-line and...

Bath & Body Works (NYSE:BBWI) Passes the Dividend Quality Screen for Income Investors ↗

Today 5:10 EDT

Five Below (NASDAQ:FIVE) Meets All Eight Growth Criteria With Improving Fundamentals ↗

Today 5:00 EDT

News headline image

Popular (BPOP) To Report Earnings Tomorrow: Here Is What To Expect

Today 4:58 EDT

Puerto Rican financial institution Popular (NASDAQ:BPOP) will be reporting earnings tomorrow morning. Here’s what you need to know. Popular beat analysts’ re...

News headline image

Byline Bancorp (BY) Reports Earnings Tomorrow: What To Expect

Today 4:57 EDT

Regional banking company Byline Bancorp (NYSE:BY) will be announcing earnings results tomorrow after the bell. Here’s what to expect. Byline Bancorp beat ana...

News headline image

Valley National Bank (VLY) Reports Earnings Tomorrow: What To Expect

Today 4:57 EDT

Regional banking company Valley National Bancorp (NASDAQ:VLY) will be reporting results tomorrow morning. Here’s what you need to know. Valley National Bank ...

News headline image

Here's How Much Enbridge (ENB) Stock You'd Need to Earn $1,000 in Dividend Income Each Year. ↗

Today 4:54 EDT

This high-yielding pipeline stock could be on the verge of increased dividend growth in the years ahead.

Via The Motley Fool

Palantir (NASDAQ:PLTR): High Growth Momentum Meets a Breakout Setup ↗

Today 4:41 EDT

Analog Devices (NASDAQ:ADI): Strong Growth Backed by a Constructive Technical Setup ↗

Today 4:30 EDT

Steel Dynamics (NASDAQ:STLD): High Growth Momentum Meets a Breakout Setup ↗

Today 4:20 EDT

Simply Good Foods (NASDAQ:SMPL): A Quality Stock With a Top-Line Caveat ↗

Today 4:11 EDT

ENERSYS (NYSE:ENS): A Growth-at-a-Reasonable-Price Industrial Candidate ↗

Today 4:00 EDT

News headline image

Comcast Trades at 6 Times Earnings and Yields 6%. Does It Deserve to Be One of the Cheapest S&P 500 Dividend Stocks, or Is This a No-Brainer Buying Opportunity? ↗

Today 4:40 EDT

Comcast's upcoming spinoff plans may not be the silver bullet for the stock's poor performance.

Via The Motley Fool

News headline image

Trumpflation Is Evolving, and There's a New Twist That Threatens to Sink Stocks ↗

Today 4:26 EDT

Trumpflation is no longer just a story about higher fuel costs.

Via The Motley Fool

News headline image

Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice ↗

Today 4:22 EDT

This company made headlines with its coronavirus vaccine.

Via The Motley Fool

News headline image

Crypto and Beyond? Here's Why Robinhood is a Better Buy Than Coinbase Today ↗

Today 4:20 EDT

Coinbase dominates crypto infrastructure with a 17.6% net margin, while Robinhood's broader platform delivered 51.6% revenue growth, but their balance sheets and regulatory risks paint very different...

Via The Motley Fool

News headline image

Is Ares Capital Stock a Buy, Sell, or Hold Below Its Net Asset Value? ↗

Today 4:15 EDT

Wait for the upcoming earnings report before buying this high-yield dividend stock.

Via The Motley Fool

News headline image

Micron and Nvidia Are the 2 Biggest Drivers of S&P 500 Earnings Growth. Are Their Stocks Buys? ↗

Today 4:04 EDT

Take out two chipmakers, and the index's third-quarter earnings growth rate falls by almost a third. So why are both stocks far below their peaks?

Via The Motley Fool

News headline image

Maximus to Buy Agile Defense for $660M, Expanding AI and Cybersecurity Reach ↗

Today 3:02 EDT

Maximus (NYSE:MMS) said it has agreed to acquire privately held Agile Defense for $660 million, with a potential future earn-out of up to $50 million, as the government-services company seeks to expand...

News headline image

Spero Therapeutics Targets 2027 Phase II Launch for SP001 in IgG4-Related Disease ↗

Today 2:02 EDT

Spero Therapeutics (NASDAQ:SPRO) plans to initiate a Phase II trial of its lead immunology candidate, SP001, in immunoglobulin G4-related disease, or IgG4-RD, in the second quarter of 2027, Chief...